Alyeska Investment Group
MBIO icon

Alyeska Investment Group’s Mustang Bio MBIO Stock Holding History

Alyeska Investment Group’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-496
Closed -$1.18M – 544
2020
Q2 		$1.18M Buy
+496
New +$1.16M 0.02% 393
2019
Q3 		– Sell
-221
Closed -$610K – 463
2019
Q2 		$610K Buy
+221
New +$631K 0.01% 397

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Alyeska Investment Group's MBIO Position: Q3 2020 in Review

Alyeska Investment Group sold out of Mustang Bio (MBIO) in Q3 2020, closing a stake of 496 shares — an estimated $1.18M sold.

Alyeska Investment Group first reported a position in MBIO in Q2 2019 and held it in 2 quarters. The position peaked at $1.18M in Q2 2020. 75 funds tracked by Wall St. Rank hold MBIO as of Q3 2020.

  • Alyeska Investment Group reported no remaining Mustang Bio position as of Q3 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 496 Mustang Bio shares in Q3 2020, an estimated $1.18M.
  • Alyeska Investment Group first reported a position in Mustang Bio in Q2 2019 and held it in 2 quarters.
  • Alyeska Investment Group's Mustang Bio position peaked at $1.18M in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2020.

Based on Alyeska Investment Group's 13F filing for Q3 2020, filed 16 Nov 2020.